Indicators of Inflammation and Coagulation in Sepsis
Completed
- Conditions
- Sepsis
- Registration Number
- NCT01128283
- Lead Sponsor
- University of Oklahoma
- Brief Summary
We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.
- Detailed Description
After informed consent is obtained 5 cc of blood is collected on the day of admission and on days 0, 1, 3, and 7 thereafter. Plasma is collected and frozen for the subsequent measurement of biomarkers.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Admission to the ICU
Exclusion Criteria
- No blood draws scheduled
- Hemoglobin level < 6,5 gm/dl
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death 30 days Survival at 30 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
OU Medical Center
🇺🇸Oklahoma City, Oklahoma, United States